Therapeutic goods regulation
The regulatory framework reflects and upholds the Australian community’s expectations around the safety and quality of therapeutic goods on the market.
Latest alerts
-
MAXMAN tablets pose a serious risk to your health and should not be taken.
-
Gold Max Blue capsules pose a serious risk to your health and should not be taken.
-
Dynamint X tablets pose a serious risk to your health and should not be taken.
Latest articles
-
Have your say to help improve the TGA website
Your feedback is essential to shaping a user-friendly website that works better for everyone. -
Recall reforms update and new procedure
Recall reforms program update and preview of the PRAC Version 1.0. -
Our Guidance pages have changed
We have introduced new features to improve your experience using Guidance on our website.
Latest publications
-
Read our 2024 stakeholder survey report, which aims to improve the way we work with our stakeholders.
-
Communique from the meeting of the TGACC
-
This Cost Recovery Implementation Statement (CRIS) 2024-2025 provides information on how we implement, and cost recover our regulatory activities.